Anja O. Knudsen
Odense, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohort.
Journal: Translational oncology
Published: May 24, 2025
A Novel Case of Indolent T-Lymphoblastic Proliferation in Metastatic High-Grade Serous Adenocarcinoma.
Journal: International journal of laboratory hematology
Published: April 25, 2025
Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy-the DANGER-emesis study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 23, 2024
Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer.
Journal: Journal of comparative effectiveness research
Published: December 06, 2024
NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer.
Journal: Gynecologic oncology
Published: November 14, 2024
Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer.
Journal: Cancer research communications
Published: May 24, 2024
Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer.
Journal: Clinical therapeutics
Published: January 30, 2024
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Journal: Gynecologic oncology
Published: December 06, 2023
Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
Journal: Pleura and peritoneum
Published: November 23, 2023
Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer.
Journal: Journal of clinical medicine
Published: November 05, 2023
Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study.
Journal: Annals of surgical oncology
Published: September 26, 2022
Development, implementation and evaluation of patient decision aids supporting shared decision making in women with recurrent ovarian cancer.
Journal: PEC innovation
Published: April 21, 2022
Last Updated: 09/26/2026